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ABSTRACT
Introduction Unfortunately, like many other health
risks, smoking rate has been on the rise in developing
countries. Half of current smokers in the world reside
in only three countries of Asia that include India. Many
smoking cessation interventions that were developed and
successfully implemented in the context of developed
countries have not been equally successful in South Asia.
Hence, there is a dire need of culturally relevant smoking
cessation interventions. We propose a scoping review with
objectives to explore the extent and nature of interventions
for smoking cessation and its associated factors in South
Asian Region by systematically reviewing the available
published and unpublished literature.
Methods and analysis The review has been registered
in Joanna Briggs Institute (JBI) systematic reviews register
and details are given in the Methodology section. The
updated framework of JBI for scoping review methodology
will be used as guide for conduct of this scoping review.
Electronic databases (PubMed, CINAHL plus, Proquest
Theses and Dissertations, EBSCO Dentistry and Oral
Sciences, and Wiley Cochrane Library), reference lists of
selected studies and grey literature will be considered for
inclusion in this review. The literature search is anticipated
to be carried out in December–January 2020. Initially,
two reviewers in consultation with a librarian will develop
search syntax followed by search from the selected
sources. Consequently, the reviewers will screen all the
titles, abstracts and full articles to establish relevance
of each study for inclusion. Factors associated with
smoking cessation will be coded and categorised applying
qualitative content analysis, while interventions extracted
from the literature will be described with the stated level of
effectiveness.

INTRODUCTION
Globally, in a year over 6 million people die
due to causes related to tobacco use. This
number is anticipated to reach approximately 8.3 million/year by 2030, primarily
due to increasing prevalence of tobacco use
in low-
income and middle-
income countries.1 2 The increasing prevalence of cigarette
smoking and its hazardous consequences are
documented extensively. It is estimated that,
globally, 942 million men and 175 million
women over age 15 years are daily smokers;
consequently, cigarette smoking is the single

Strengths and limitations of this study
►► The review includes content in any language with

English translation available and search in three
different ways from South Asian Region (SAR), thus,
increasing the chances of covering a broader range
of work done on phenomena of interest.
►► Most of the team members in this review are experts of systematic reviews who will ensure each
step carried out with utmost accuracy.
►► One of the strengths of this review is engagement of
stakeholders and relevant organisations during the
review process.
►► The quality of included studies will not be ensured
through an established tool, although some more recent scoping review protocols have used tools such
as the Newcastle–Ottawa Scale.
►► Literature published in languages other than English
will not be included that may affect the scope of
the review. However, preliminary search shows
rare availability of literature in language other than
English in SAR.

leading cause of preventable diseases and
deaths making it a critical public health
challenge.3 4Cigarette smoking leads to a
range of health problems that either affect
the quality of life or become the reason for
premature death. Smoking tobacco exposes
the smoker’s body to over 7000 toxic chemicals that include a minimum of 70 carcinogens affecting almost every body system.3
Significant health problems due to smoking
include cardiovascular (mainly coronary
heart) diseases and respiratory diseases,
mainly cancer.5 6 Moreover, smoking is a risk
factor for congenital disorders in the case of
pregnant smokers, stroke, peripheral vascular
diseases, cerebrovascular disease, renal
failure, intestinal ischaemia and impotence
to name a few.3 7 Furthermore, although the
consequences of smoking are largely associated with the number of cigarettes smoked, a
lifelong regular smoker loses approximately
10 years of life to smoking.3 Of importance
are the benefits of non-smoking or smoking
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Definitions of terms
Smoker
Smoker is defined as a person who smoked at least once
daily in the last 30 days.
Smoking cessation rate
Smoking cessation rate (outcome measure) in this study
is defined as the decrease in number of cigarettes per day
in comparison with the pre-intervention phase.
Smoking cessation intervention
Any action intended to increase cigarette smoking
cessation rate will be referred as smoking cessation
intervention.
South Asian Region
South Asia is one of the most populated geographical
regions inhabited by almost a quarter of the world’s
population.9 South Asian Region (SAR) includes Pakistan, India, Sri Lanka, Afghanistan, Bangladesh, Nepal,
Bhutan and Maldives.10 Three of the countries (Pakistan, India and Bangladesh) mentioned in the above list
are partition of one country, that is, British India,9 thus,
sharing numerous cultural and religious traits. Besides, a
common issue faced by people in countries of SAR is their
lack of awareness of different health risks and low level of
education. Sreeramareddy et al found that in two of the
countries in SAR (ie, Bangladesh and Maldives), one in
three men between 15 and 49 years is not educated, while
17.1%–56.2% women of aged 15–49 years were uneducated.11 The study also emphasised on negative association of education level with smoking behaviour.11
Smoking is the most common health risk found high in
South Asian population.1 2 A study on Asian population
reports that serving tobacco products is a cultural norm
and dignity of Asian people.12 Concurrently, the study
by Sreeramareddy et al found the prevalence of smoking
among men aged between 15 and 49 years as 60% in
Bangladesh, 47.3% in Maldives, 34.1% in India, 33.6% in
Nepal and 31.6% in Pakistan.11 The study also concluded
that smoking in South and Southeast Asian countries is
more common among men from low economic backgrounds, uneducated or residents of rural areas.11
Therefore, consideration of the context-specific factors
associated with smoking is important in planning strategies for prevention and control of cigarette smoking.
2

Study rationale
Despite claims by different countries regarding progress towards achievement of their smoking cessation
goals, globally the decline in smoking prevalence has
been slower in the last 10 years (2005–2015) than in the
past (1990–2005).13 In developed countries, efforts for
smoking cessation remained quite effective due to factors
like good public awareness, availability of resources
for smoking cessation and uniform policies towards
smoking cessation; whereas, in low-income and middle-
income countries, the smoking cessation rate remained
discouraging.14–16 Consequently, if the current situation
sustains, as predicted, by 2030, almost 80% of tobacco-
related deaths will be in low-income and middle-income
countries.17
Although systematic reviews either based on data from
one specific country18 or general global data19 have been
carried out, no review of smoking cessation interventions
in SAR countries has been conducted on smoking cessation and its associated factors. The strict inclusion criteria
of previously conducted systematic reviews might have
significantly reduced the inclusion of available data on
the phenomena of interest. Therefore, a scoping review is
proposed with primary outcome to summarise the current
scope of interventions and critical factors to be considered while planning any smoking cessation intervention.
This will help in achieving secondary outcome, that is,
to enhance effectiveness of the developing strategies for
reduction of smoking prevalence in SAR. Moreover, the
increasing prevalence of smoking in SAR signifies the
imperative for reconsideration of the strategies implemented for smoking cessation in this region. Therefore,
it is important to explore the range and nature of these
strategies to align them, through further research, with
local contextual factors to potentiate achievement of
optimal outcomes.
Why a scoping review?
Scoping review is an approach that covers underpinning
concepts surrounding the phenomenon of interest20
thus, giving a broader image that serves as a precursor
to systematic reviews.21 Also, scoping reviews give depth
and breadth of the research work done on a topic,
thus increasing the understanding of the nature of the
phenomenon under investigation.22
Effective interventions to stop or control the current
pattern of smoking are emerging and evolving constantly.
Due to this variability and complexity, there is a need
to collate evidence related to interventions for smoking
cessation among South Asian population and distinguishing the underpinning forces that encourage or
discourage the behaviour of smoking. Given the range
of programmes, national initiatives/policies and potential interventions, it is desirable that the least restrictive
design for a review be selected to maximise the diversity
for smoking cessation strategies in SAR. We want to take
into account the cultural specific measures or interventions which are not formally reported or not publicly
Iqbal S, et al. BMJ Open 2021;11:e038818. doi:10.1136/bmjopen-2020-038818
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cessation. Quitting before age 40 years saves about 9 years
of life because cessation at this age reduces the risk of
death due to smoking-
related morbidities by 90%.3 A
smoker can also benefit from smoking cessation even
after the development of smoking-related diseases such
as chronic obstructive pulmonary diseases and cardiovascular diseases.8
Hence, smoking is likely one of the most lethal and
prevalent yet preventable health risk behaviours in today’s
world. Its increasing epidemic levels should catalyse the
need for better smoking cessation measures.
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METHODOLOGY AND ANALYSIS
The title of this protocol has been registered with
‘Joanna Briggs Institute (JBI) systematic review register’
page 10, on 28 January 2020 and can be found on their
website
(https://jbi.global/systematic-review-register?
combine=&items_per_page=10&page=17&order=title&
sort=asc).
Besides, the conduct and reporting of the scoping
review report will be guided by the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
extension for Scoping Review as recommended in literature.23 24 Moreover, to advance the development process
and reporting of this protocol, the recommended
PRISMA-
Protocols checklist was used25 (attached as
online supplemental appendix 1). In addition, the record
and data of the review will be saved in a computer and in
a hard drive for back-up. Also, the computer files will be
connected to campus cloud in order to secure the data.
This review will be part of a multiphasic mixed-method
research to include contextually relevant smoking cessation interventions and associated factors that will help
in the development of a model for smoking cessation
in SAR. Since the review is from existing published and
publicly available literature, it does not require an ethical
approval. A tentative timeline for the conduction of the
review is attached as online supplemental appendix 2.
Patient and public involvement
This review will not include any research participants or
patients for data collection. The stakeholders’ involvement in initial planning and research question setting
will be acknowledged in the original report of the review
as per their permission. Moreover, the findings of the
proposed review will be disseminated to smokers and
relevant stakeholders to encourage their involvement in
further planning for smoking cessation.
Protocol design
The JBI guidelines proposed by Peters et al24 underpinned
by the framework presented by Arksey and O’Malley20
and Levac et al26 will guide the scoping review to examine
the extent and nature of work done on smoking cessation in SAR with the factors impacting these efforts.
Thus, the review will be carried out in the nine stages
mentioned herein. Also, we have experts in our team who
have worked on topic of the scoping review. In addition
to that, we will consult a smoking cessation consultant
(JA) available in our university. The stated expertise will
Iqbal S, et al. BMJ Open 2021;11:e038818. doi:10.1136/bmjopen-2020-038818

be instrumental in how to conduct an informed search,
review and synthesis process.
Stage 1: defining and aligning the objective/s and question/s
The scoping review is planned to systematically search
literature across the range and nature of interventions
for smoking cessation and to map the factors associated
with such interventions. Following this, questions for the
proposed scoping review are designed as: what is known
from existing literature about the range of interventions/
control measures devised for smoking cessation in SAR?
and What are the factors associated with smoking cessation in SAR in the available literature?
Stage 2: developing and aligning the inclusion criteria with the
objective/s and question/s
Aligned with the questions and objectives of the review,
studies regardless of design including qualitative studies,
randomised controlled trials, quasi-experimental studies,
case–control studies, cohort studies, or descriptive studies
addressing the phenomenon of smoking cessation or
intervening smoking behaviour or factors associated with
smoking cessation or combination of one or more of
these phenomena will be included. The target population
of the included studies will be adults (age above 18 years)
from any country in SAR. Literature written in English or
any other language with English translation available will
be included. Furthermore, due to rich availability of data,
studies published within 5 years from search date will be
included.
Studies will be excluded if not available as free full text.
Moreover, studies having participants from any country
other than countries in SAR will not be included.
Stage 3: describing the planned approach to evidence searching,
selection, data extraction and presentation of the evidence
Initially, two reviewers will extensively search the selected
databases (PubMed, CINAHL, Proquest Theses and
Dissertations, EBSCO Dentistry and Oral Sciences, and
Wiley Cochrane Library) for relevant qualitative and
quantitative data on the phenomena of interest during
the period mentioned in the timeline. PubMed is recommended for inclusion in systematic/scoping reviews as it
covers an extensive range of literature.27 Moreover, most
of the rest are health-related literature databases; therefore, their inclusion in the present scoping review can add
significant data on preventing health hazards of smoking
through different interventions. CINAHL, on the other
hand, is a specialised database for nursing-related literature,27 thus adding to the phenomenon from nursing
lens and broadening the range of the data beyond positivist view.
The anticipated dates for the literature search are
mentioned in online supplemental appendix 2. The literature search will be carried out in the four steps discussed
below in the Search strategy section. To maintain a
rigorous record of the searched literature, the PRISMA
flow diagram will be used.
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available. Additionally, in this study we are not focusing
on a clinical question which would more closely align with
a systematic review, whereas, the scoping review is more
aligned with mapping the evidence related to the types
of smoking cessation interventions and the characteristics
of individuals accessing such programmes.21 After consideration, a scoping review was deemed as best serving the
aim of this study.

Open access

PubMed search conducted in November 2020.

Stage 4: searching for the evidence
Step 1
After a thorough discussion with research team and
the librarian on the selection of appropriate keywords,
controlled vocabulary and going through relevant literature, the following key terms supported by Medical
Subject Headings (MeSH) terms, Boolean phrases
and wildcards were considered for literature search:
tobacco, cigarette, smoking cessation, quit, interventions,
measures, strategies and South Asian Region. Consequently, a nested search syntax was developed as, (Intervention* OR measure* OR strateg* OR program) AND
(“Smoking”[Mesh] OR smok* OR Tobacco OR Nicotine
OR Cigarette) AND (“Smoking Cessation”[Mesh:NoExp]
OR Cessation OR Quit*) AND (“South Asia*” OR Pakistan OR Afghanistan OR Bangladesh OR Bhutan OR
India OR Nepal OR Maldives OR Sri Lanka). The filters
applied included full-
text articles and publications in
the last 5 years. The mentioned key terms were used to
develop full strategy for search in PubMed (attached as
figure 1 in image).
Step 2
The reference list of selected articles will be manually
checked and identified relevant references will be used
for additional article retrieval through citation chaining.
This will also assist in identifying relevant organisational
websites in SAR.
Step 3
Hand searching of print journals will be carried out in
order to capture the literature available in library that
might have been missed while searching through selected
search engines.
Step 4
Data received through coordination with other research
colleagues or key informants, information printed in
4

alternate formats (ie, reports, briefs), and any available
unpublished material will be sought and reviewed for
relevancy to the intent of this review. Unpublished literature search will be supported through email contacts with
authors of published articles to share any source of grey
literature. Moreover, we will access Proquest Theses and
Dissertations Database, OpenGrey database and Higher
Education Commission Research Repository. Also, we will
use the WHO country reports on cigarette smoking.
Stage 5: selecting the evidence
Based on relevance, accessed studies will be considered
for inclusion through EndNote software. Initially, two
reviewers will independently read the title and abstract
of a retrieved study. Based on relevancy, the reviewers will
recommend, include or exclude. Then, individually, the
reviewers will read the included full-length articles and
independently rate the appropriateness of the article
or any reading material for inclusion. The reviewers
will then cross check the list of included and excluded
studies. If any discordance occurs respecting inclusion or
exclusion of any full-text article or any other material (eg,
reports, brief and so on) selected at the preliminary stage,
the article or other material will be reread; and if still
not clear to include or exclude, a third reviewer will be
involved to build consensus. The appropriateness of the
selected material will be based on inclusion criteria and
authenticity of the publishing authority or of the organisation to which unpublished work is associated.
Stage 6: extracting the evidence
Data will be collected using a study instrument developed by researchers that include, but not limited to,
study reference, location, participants’ characteristics
(ie, age, gender and ethnicity), methodology, research
purpose, data collection and main relevant outcomes.
This analytical form will be pretested and discussed with
Iqbal S, et al. BMJ Open 2021;11:e038818. doi:10.1136/bmjopen-2020-038818

BMJ Open: first published as 10.1136/bmjopen-2020-038818 on 9 February 2021. Downloaded from http://bmjopen.bmj.com/ on March 2, 2021 at Aga Khan University. Protected by
copyright.

Figure 1
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Stage 7: analysis of the evidence
The scoping reviews aim to develop a map of the underpinning concepts of the selected research area, the formulation of results leads to the range of work being done.27
The proposed review will extract the extent and nature of
work done for smoking cessation as well as the range of
factors that might have affected such work. Furthermore,
the review will not weigh or assess the impact of the interventions on smoking cessation as they all will be taken
into consideration to further guide the linear analysis
process described here. In the proposed scoping review,
the extracted interventions will be coded based on the
Framework Convention on Tobacco Control set forth by
the WHO,29 and the smoking cessation-associated factors
will be coded thematically. All the factors that have been
described in selected studies, reports or briefings will be
colour coded. Based on the nature of codes, they will be
put under relevant categories, such as personal factors,
social factors and so forth. Finally, according to the focus
of categories, themes will be assigned to make it more
comprehensible.
To clarify the results, quantitative and qualitative
studies will be synthesised separately. First, individually,
both reviewers will summarise findings from all included
studies. Second, the reviewers will discuss their findings
and will merge them. Findings will then be shared with
the whole research team including the supervisor of the
study.
To minimise bias arising from personal values, preconceptions and judgements, the reviewers will undertake
bracketing before data collection. The review process
will involve two or more members of the research team
in conducting the reviews in order to ensure capturing/
revealing multiple perspectives. Moreover, reviewers will
maintain a diary to capture their feelings and learning
experience in real time. In order to keep an organised
and detailed record of reflexive bracketing, an iterative
process of reflexive journey will be maintained throughout
the review process.30 Through these strategies, we believe
reflexivity will be achieved.
Stage 8: presentation of the results
The findings of this review will be presented in tables,
appropriate diagrams and texts. The findings of the
review will be shared through publications, posters,
conference presentations and meetings with different
stakeholders.
Iqbal S, et al. BMJ Open 2021;11:e038818. doi:10.1136/bmjopen-2020-038818

Stage 9: summarising the evidence in relation to the purpose of
the review, making conclusions and noting any implications of the
findings
Based on the findings, inferences will be drawn for presentation of the whole scenario with clarity and brevity. Moreover, recommendations will be set forth to make effective
use of the findings in future planning for smoking cessation in SAR.
Ethics and dissemination
The study does not require an ethical approval. However,
every effort will be put to maintain transparency in the
conduct of the study. The results of this scoping review
will be disseminated through publications, presentations
in conferences and meetings with stakeholders.
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meetings with the librarian and reviewers to finalise the included databases,
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the whole activity and made sure that all requirements of a scoping review are
covered in the protocol. PP contributed to shaping up the idea of the scoping
review. She suggested the idea of conducting the review in SAR. Also, she shared
her expert opinion on overall conduct of the study. LL contributed to selection of
database inclusion for the review. Also, she did major editing on the initial draft of
this protocol. She will also contribute to the literature review process.
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